| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,789,112 | 3,000,868 | 3,963,883 | 3,264,271 | | Cost of Revenue | 1,871,068 | 1,644,490 | 2,092,362 | 838,335 | | | Gross Profit | 918,044 | 1,356,378 | 1,871,521 | 2,425,936 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 153,665 | 725,402 | 855,774 | 1,609,850 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 257,852 | 274,243 | 263,655 | 247,977 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 506,527 | 356,733 | 752,092 | 568,109 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 37,425 | 41,550 | 31,041 | 36,281 | | Earnings Before Interest And Taxes | 540,825 | 388,641 | 794,565 | 591,845 | | Interest Expense | 137,446 | 159,325 | 156,035 | 137,879 | | Income Before Tax | 403,379 | 229,316 | 638,530 | 453,966 | | Income Tax Expense | 163,046 | 58,742 | 168,241 | 183,012 | | Minority Interest |
-
|
-
| 9,973 | (9,973) | | | | Net Income From Continuing Ops | 240,333 | 170,574 | 470,289 | 270,954 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 240,333 | 170,574 | 470,289 | 270,954 | | Preferred Stock And Other Adjustments | (4,998) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $235,335 | $170,574 | $470,289 | $270,954 |
|
0.45% Nasdaq 
0.20%
Income Statement
